{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19645247", "DateCompleted": {"Year": "2009", "Month": "12", "Day": "29"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-4454", "JournalIssue": {"Volume": "32", "Issue": "4", "PubDate": {"Year": "2009", "Month": "Apr"}}, "Title": "Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials", "ISOAbbreviation": "Zhong Yao Cai"}, "ArticleTitle": "[Study on the inhibitory effect of Reduqing Oral Liquid on respiratory syncytial virus in vitro].", "Pagination": {"StartPage": "579", "EndPage": "581", "MedlinePgn": "579-81"}, "Abstract": {"AbstractText": ["To explore the antiviral effect of Reduqing Oral Liquid on respiratory syncytial virus (RSV).", "The anti-RSV effect of Reduqing Oral Liquid in Hep-2 cell culture was investigated by the cytopathic effect (CPE) inhibition assay and MTT assay, with ribavirin as the positive control drug.", "Reduqing Oral Liquid was effectively antiviral agent for RSV in a concentration-dependent manner in vitro. The median toxic concentration (TC50) was 9182.4 mg/L, the median effective concentration (EC50) was 559.8 mg/L and the treatment index (TI) was 16.4.", "Reduqing Oral Liquid has obvious inhibitory effect on RSV in vitro."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Anhui Medical University, Hefei 230032, China. shhuang@ahmu.edu.cn"}], "Identifier": [], "LastName": "Huang", "ForeName": "Sheng-Hai", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Feng", "ForeName": "Xiao-Liang", "Initials": "XL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Wei", "Initials": "W"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhong Yao Cai", "NlmUniqueID": "9426370", "ISSNLinking": "1001-4454"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "49717AWG6K", "NameOfSubstance": "Ribavirin"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Respiratory Syncytial Viruses"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ribavirin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "8", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "8", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "12", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19645247"]}}], "PubmedBookArticle": []}